Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Revvity, Inc. logo

Revvity, Inc. (RVTY) Stock Ticker

NYSE: RVTY · Healthcare · Medical - Diagnostics & Research
$151.02+0.29%
USD · as of 2026-09-29 · market cap $16.9B
Open RVTY in TickrRead the RVTY AI analysisDownload for iPhone

RVTY right now

Trading at the top of its 52-week range.
Options expect by Oct 6±6.4%
Options expect by Oct 29±13.2%
Priced in for Oct 26 earnings±12.5%
IV rank (30-day)71% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full RVTY picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on RVTY
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Revvity, Inc.

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.

RVTY stock facts

Ticker symbolRVTY
ExchangeNew York Stock Exchange
SectorHealthcare
IndustryMedical - Diagnostics & Research
Market cap$16.9B
CEOPrahlad R. Singh
Employees11,000
HeadquartersWaltham, MA, US
IPO date1965-07-06
Websitewww.revvity.com

What you can see for RVTY on Tickr

Live RVTY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the RVTY report.

Rankings

Largest Healthcare companiesLargest companies by market cap

RVTY peers

ALGNCRLENSGEXASGHHIMSICLRQGEN

FAQ

What is the ticker symbol for Revvity, Inc.?

The ticker symbol for Revvity, Inc. is RVTY, listed on the New York Stock Exchange.

What is RVTY?

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced…

HomeExploreMarketLists
All pages